Moderna
MRNA
#1365
Rank
HK$102.71 B
Marketcap
HK$265.68
Share price
4.62%
Change (1 day)
-69.23%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total debt

Total debt on the balance sheet as of December 2024 : HK$5.80 Billion

According to Moderna 's latest financial reports the company's total debt is HK$5.80 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Moderna - Total debt on balance sheet (from 2017 to 2024)

Total debt by year

Year Total debt Change
2024-12-31HK$5.79 B-40.26%
2023-12-31HK$9.70 B3.54%
2022-12-31HK$9.37 B31.27%
2021-12-31HK$7.14 B288.76%
2020-12-31HK$1.83 B78.23%
2019-12-31HK$1.03 B293.09%
2018-12-31HK$0.26 B113.97%
2017-12-31HK$0.12 B26.44%
2016-12-31HK$96.93 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
HK$2.13 M-99.96%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$288.54 B 4,868.01%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.14 B-97.51%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$10.07 B 73.50%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$243.03 B 4,084.47%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
HK$4.08 B-29.68%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$284.83 B 4,804.15%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA